Results 241 to 250 of about 4,045,707 (379)
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
Amber-red color imaging for enhanced visualization and hemostasis during rectal endoscopic submucosal dissection. [PDF]
Huang CW, Chen YY, Yen HH.
europepmc +1 more source
Flow Visualization with Stereo Shadowgraphs of Stratified Fluid [PDF]
C. W. McCutchen
openalex +1 more source
Artemis: sequence visualization and annotation
Kim M Rutherford +6 more
semanticscholar +1 more source
VISUAL EXPECTATIONS AND VISUAL IMAGINATION [PDF]
openaire +3 more sources
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
SBMLNetwork: A framework for standards-based visualization of biochemical models. [PDF]
Heydarabadipour A +3 more
europepmc +1 more source
IMPROVED STAIN FOR VISUALIZATION OF AZOTOBACTER ENCYSTMENT
G. R. Vela, Orville Wyss
openalex +1 more source
Direct visualization of T lymphocytes bearing Ia antigens controlled by the I-J subregion [PDF]
Christopher R. Parish, IFC McKenzie
openalex +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga +8 more
wiley +1 more source

